Login / Signup

Selectivity Challenges in Docking Screens for GPCR Targets and Antitargets.

Dahlia R WeissJoel KarpiakXi-Ping HuangMaria F SassanoJiankun LyuBryan L RothBrian K Shoichet
Published in: Journal of medicinal chemistry (2018)
To investigate large library docking's ability to find molecules with joint activity against on-targets and selectivity versus antitargets, the dopamine D2 and serotonin 5-HT2A receptors were targeted, seeking selectivity against the histamine H1 receptor. In a second campaign, κ-opioid receptor ligands were sought with selectivity versus the μ-opioid receptor. While hit rates ranged from 40% to 63% against the on-targets, they were just as good against the antitargets, even though the molecules were selected for their putative lack of binding to the off-targets. Affinities, too, were often as good or better for the off-targets. Even though it was occasionally possible to find selective molecules, such as a mid-nanomolar D2/5-HT2A ligand with 21-fold selectivity versus the H1 receptor, this was the exception. Whereas false-negatives are tolerable in docking screens against on-targets, they are intolerable against antitargets; addressing this problem may demand new strategies in the field.
Keyphrases
  • molecular dynamics
  • molecular dynamics simulations
  • chronic pain
  • pain management
  • protein protein
  • high throughput
  • mental health
  • binding protein
  • drug delivery
  • cancer therapy
  • single cell